November 12, 2014 C P
Transcription
November 12, 2014 C P
November 12, 2014 Crowne Plaza Reading 1741 Paper Mill Road Wyomissing, PA 19610 Symposium Registration Agenda 8:00 am – 8:45 am 8:45 am – 3:00 pm Register Invitees must submit the attached registration form to Homeland Security. A confirmation email will be sent upon receipt of the registration. Contact Phone Email 717-346-4461 [email protected] Continuing Medical Education for physicians Continuing Education Credits for emergency medical service personnel Act 48 Credits /Act 58 Credits for educators and registered nurses This symposium will provide information on bio pathogens and the integrated response of the medical, first responder and law enforcement communities. Subject matter experts from the FBI, US Dept. of Homeland Security, PA Dept. of Health, PA National Guard and medical professionals will identify, and with the audience explore the diagnosis, investigation and treatment process of the patient/population and the subsequent law enforcement response if the incident is defined to be a criminal/terrorist event. The symposium is free of charge with a working lunch. Continuing education credits are available for physicians, registered nurses, emergency medical service personnel and educators. Confronting the Global Threat: Bioterrorism Agents/Diseases Subject Matter Experts Jeffrey Backer, Director - Planning and Operations Division, Bureau of Public Health Preparedness, PA Dept. of Health Mr. Backer will discuss Pennsylvania's capabilities with the respect to the Bio Annex to the National Response Plan. Charles F. Barbera, MD, MBA, FACEP, Chairman, Dept. of Emergency Medicine – Reading Health System Dr. Barbera will speak about emergency room and hospital operations when confronted with a terrorist or non-terrorist related bio pathogen. Kevin Bosch, Special Agent - Federal Bureau of Investigation Special Agent Bosch will speak on the role, responsibilities and authorities of the FBI in a suspected or known criminal bio attack and the FBI’s capabilities locally and nationally. He will speak about the joint Crim/Epi investigative model and evidence handling, processing and chain of custody matters. He may draw upon specific cases, incidents and threats. Major Russ Flick, Commander, Civil Support Team (CST), PA National Guard Major Flick will discuss the CST’s immediate, deployable capabilities in a hazardous material incident or in the event of the use of a Radiological, Nuclear, Chemical or Biological Weapon of Mass Destruction. Selwyn “Jamie” Jamison, Bio Terrorism National Program Manager - Federal Bureau of Investigation Mr. Jamison will speak on the National Policy and the National Strategy regarding the bio threat. He will focus on specific national initiatives to counter a biological attack. He will identify and describe efforts to build capabilities across the country and will speak on national security staff efforts to maintain awareness of bio threats and to coordinate the bio agent threat response. Julia A. Kiehlbauch, Ph.D., D(ABMM), Director - Bureau of Laboratories, PA Dept. of Health Dr. Kiehlbauch will discuss a variety of potential bio pathogens including those organisms traditionally associated with biological terrorism, and other agents that might be used as a weapon, and those that are emerging as potential agents of concern. She will discuss how these agents might be used with respect to a scenario involving a health care institution and methods that might be used to identify them in a situation. She will also offer considerations for situations precipitated by potential terrorist actions. Bill Ryan, Protective Security Advisor - US Dept. of Homeland Security PSA Ryan will address common vulnerabilities concerning security at hospitals, and associated protective measures to reduce those vulnerabilities. Irshad Shaikh, MD, PhD, MPH, Director - Bureau of Epidemiology, PA Dept. of Health - or – Jeffrey R. Miller, MD, MPH, CDC Career Epidemiology Officer - PA Department of Health Dr. Shaikh or Dr. Miller will discuss the epidemiologic investigation and response that occurs in an outbreak. He will also discuss the process of investigation that is used to provide information about the origins of an event, and will describe how a health care facility might interact with the Department of Health during an investigation.
Similar documents
Global Growth of Bio Active Protein and Peptides Market
Global Growth of Bio Active Protein and Peptides Market Sales revenue of bio active protein and peptides in Japan is anticipated to increase at the highest Y-o-Y growth rate
More information